Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophic Epidermolysis Bullosa (DEB)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Large-scale testing (Phase 3)Looking for participantsNCT07016750
What this trial is testing

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 16
Not applicableLooking for participantsNCT06563414
What this trial is testing

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica Dominans
Krystal Biotech, Inc. 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07717736
What this trial is testing

Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds

Who this might be right for
Epidermolysis Bullosa (EB)Recessive Dystrophic Epidermolysis Bullosa (RDEB)Dystrophic Epidermolysis Bullosa (DEB)
Abeona Therapeutics, Inc 100
Not applicableWithdrawnNCT04214002
What this trial is testing

The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT05725018
What this trial is testing

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

Who this might be right for
Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaRDEB
Abeona Therapeutics, Inc 12
Not applicableStudy completedNCT02178969
What this trial is testing

Short Term Observational Study in DEB Patients

Who this might be right for
Dystrophic Epidermolysis Bullosa
Shire 29
Testing effectiveness (Phase 2)Looking for participantsNCT06834035
What this trial is testing

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 8
Testing effectiveness (Phase 2)UnknownNCT05529134
What this trial is testing

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Who this might be right for
Dystrophic Epidermolysis Bullosa
Phoenicis Therapeutics 8
Early research (Phase 1)Study completedNCT03472287
What this trial is testing

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more
Castle Creek Pharmaceuticals, LLC 11
Testing effectiveness (Phase 2)Study completedNCT03536143
What this trial is testing

A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients

Who this might be right for
Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 12
Large-scale testing (Phase 3)Study completedNCT04917874
What this trial is testing

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 47
Testing effectiveness (Phase 2)UnknownNCT05157958
What this trial is testing

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 6
Large-scale testing (Phase 3)Active Not RecruitingNCT06892639
What this trial is testing

Evaluation of D-Fi for the Treatment of Wounds Due to DEB

Who this might be right for
Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences, LLC. 32
Large-scale testing (Phase 3)Study completedNCT04491604
What this trial is testing

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 31
Not applicableWithdrawnNCT02004600
What this trial is testing

Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB

Who this might be right for
Dystrophic Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589
What this trial is testing

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 18
Not applicableWithdrawnNCT01768026
What this trial is testing

Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Lotus Tissue Repair, Inc.